NCT05340959|CompletedDMC
Loading search results
Sponsor study identifier
observational
16
1 country
1
Study Start
December 15, 2021
Actual (reported)Primary Completion
September 1, 2022
Actual (reported)Study Completion
December 1, 2022
Actual (reported)A prospective observational study guided by the guidelines of Strengthening The Reporting Of Observational Study in Epidemiology (STROBE) in 2014, that will be conducted to evaluate implant stability using three devices; Osstell®, Peiotest® and AnyCheck® and comparing the results.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 15, 2021
Actual (reported)March 27, 2022
Actual (reported)April 22, 2022
Actual (reported)September 1, 2022
Actual (reported)December 1, 2022
Actual (reported)Implant stability measured by Osstell®.
Implant stability will be measured by: Osstell® (RFA) that is measured by Implant Stability Quotient (ISQ) Value.
Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).
Implant stability measured by Periotest®.
Implant stability will be measured by: Periotest® (damping effect) that is measured by Periotest Value (PTV).
Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).
Implant stability measured by AnyCheck®.
Implant stability will be measured by: AnyCheck® (tapping-motion) that is measured by Initial Stability Test (IST) Value.
Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).
Correlation between values obtained by the devices
Correlation between values obtained by: 1. Osstell® (RFA): measured by Implant Stability Quotient (ISQ) Value. 2. Periotest® (damping effect): measured by Periotest Value (PTV). 3. AnyCheck® (tapping-motion): measured by Initial Stability Test (IST) Value.
Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).
Adult patient with single or multiple missing tooth or teeth requiring dental implants, 40 dental implants will be placed in osteotomy sites based on radiographic findings (CBCT), the primary stability will be measured immediately after implant installation and secondary stability will be measured after 12 weeks . Both primary and secondary stability will be measured by three devices: 1. Osstell®: based on Resonance Frequency Analysis (RFA). 2. Periotest®: based on damping effect. 3. AnyCheck®: based on tapping-motion.
1. Osstell®: is a device that measure implant stability and based on resonance frequency analysis (RFA). Due to stiffness in the interface between the implant surface and the bone smart peg will vibrates accordingly. the more dense bone the higher stability, the higher frequency and higher Implant Stability Quotient (ISQ) value which is from 1-100. 2. Periotest®: is a device used to assess osseointegration of dental implants, so it measure implant stability . it is based on damping effect of implant. Showing the measurement digitally on a scale from -8 (low mobility) to 50 (high mobility) PTV units. 3. AnyCheck®: this is an implant stability meter that measures the stiffness of alveolar bone-implant interface through a tapping motion. Showing the measurement on a scale from 30 (low stability) to 85 (high stability).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Healthy adults with missing one or more tooth or teeth seeking for dental implant treatment.
College of Dentistry, University of Baghdad
Baghdad, Medical City, 1417, Iraq
Alamin Y. Dhahi, B.D.S
University of Baghdad
16 participants (actual enrollment reported by the registry).
First Submitted
March 27, 2022
First Posted
April 22, 2022
Study Start
December 15, 2021
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
September 1, 2022
Actual (reported)Study Completion
December 1, 2022
Actual (reported)Last Updated
October 3, 2023
Record last verified: 2023-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: